FDA Approves Label Update For Gilead's Kite's Yescarta

Gilead Sciences, Inc. +1.02% Post

Gilead Sciences, Inc.

GILD

140.45

140.37

+1.02%

-0.06% Post

– Limitations of Use Removed for Rare and Aggressive Form of non-Hodgkin Lymphoma Based on Manageable Safety Profile with No New Safety Signals Identified –